Bone Biologics Corporation narrowed III. Quarter net loss per share of $-0.12 compare to net loss per share of $-0.17 recorded in the same quarter a year ago a decrease compare to $-0.05 realized in previous quarter.
III. Quarter
Earnings Per Share
Revenues
$ -0.12
$
0 Mill
$+0.05
Unch.
Bone Biologics's Revenue
fell by
0 % in III. Quarter (Sep 30 2022) year on year,
to $0 million and
declined by
sequentially.
Bone Biologics is Expected to report next financial results on March 14, 2023.